Unexpected effect of proton pump inhibitors: Elevation of the cardiovascular risk factor asymmetric dimethylarginine

Keyphrases

• Cardiovascular Risk 100%
• Proton Pump Inhibitors 100%
• Asymmetric Dimethylarginine 100%
• Major Adverse Cardiovascular Events 25%
• Adverse Effects 12%
• Attenuation 12%
• Human Tissue 12%
• Vasoprotective Effect 12%
• Dimethylarginine Dimethylaminohydrolase 12%
• Endothelial Nitric Oxide Synthase (eNOS) 12%
• Risk for Cardiovascular Diseases 12%
• Pharmacovigilance 12%
• Biological Mechanisms 12%
• Nitric Oxide Level 12%
• Nitric Oxide Synthase Inhibitors 12%
• Treatment of Gastroesophageal Reflux Disease 12%
• Acute Coronary Syndrome 12%
• Murine Model 12%
• Acid-suppressive Agents 12%
• Level Dependence 12%
• Endogenous Inhibitor 12%
• Clinical Investigation 12%
• Gastric Acid 12%
• Endothelium-dependent Vasodilation 12%
• Coronary Disease 12%

Pharmacology, Toxicology and Pharmaceutical Science

• 6 N,n' Dimethylarginine 100%
• Proton Pump Inhibitor 100%
• N(g),n(g) Dimethylarginine 100%
• Cardiovascular Risk 100%
• Cardiovascular Disease 37%
• Adverse Event 12%
• Heart Muscle Ischemia 12%
• Acute Coronary Syndrome 12%
• Dimethylargininase 12%
• Nitric Oxide 12%
• Nitric Oxide Synthase 12%
• Endothelial Nitric Oxide Synthase 12%
• Pharmacovigilance 12%
• Gastroesophageal Reflux 12%

Medicine and Dentistry

• Proton-Pump Inhibitor 100%
• Cardiovascular Risk 100%
• N(g),n(g) Dimethylarginine 100%
• Cardiovascular Disease 37%
• Adverse Event 12%
• Nitric Oxide 12%
• Ex Vivo 12%
• Human Tissue 12%
• Acute Coronary Syndrome 12%
• Pharmacovigilance 12%
• Endothelial Nitric Oxide Synthase 12%
• Nitric Oxide Synthase 12%
• Gastroesophageal Reflux 12%
• Vasodilatation 12%
• Dimethylargininase 12%
• Heart Muscle Ischemia 12%